Osteogenic Effects of MicroRNA-335-5p/lipidoid Nanoparticles Coated on Titanium Surface
Overview
Authors
Affiliations
Objective: In this study, we aimed to investigate the therapeutic potential of miR-335-5p lipidoid nanocomplexes coated on Titanium (Ti) SLActive surface by lyophilization.
Design: In our model, we coated miR-335-5p/Lipidoid nanoparticles on titanium implant, seeded GFP-labelled mouse bone marrow stromal cells (BMSCs) onto the functionalized Ti implant surface, and analyzed the transfection efficiency, cell adhesion, proliferation, and osteogenic activity of the bone-implant interface.
Results: The Ti SLActive surface displayed a suitable hydrophilicity ability and provided a large surface area for miRNA loading, enabling spatial retention of the miRNAs within the nanopores until cellular delivery. We demonstrated a high transfection efficiency of miR-335-5p lipidoid nanoparticles in BMSCs seeded onto the Ti SLActive surface, even after 14 days. Alkaline phosphatase (ALP) activity and cell vitality were significantly increased in BMSCs transfected with miR-335-5p at 7 and 14 days as opposed to cells transfected with negative controls. When miR-335-5p transfected BMSCs were induced to undergo osteogenic differentiation, we detected increased mRNA expression of osteogenic markers including Alkaline phosphatase (ALP), collagen I (COL1), osteocalcin (OCN) and bone sialoprotein (BSP) at 7 and 14 days as compared with negative controls.
Conclusion: MiR-335-5p lipidoid nanoparticles could be used as a new cost-effective methodology to increase the osteogenic capacity of biomedical Ti implants.
Cohen D, Van Duyn C, Deng J, Lodi M, Gallagher M, Sugar J Biomimetics (Basel). 2025; 10(1).
PMID: 39851782 PMC: 11759188. DOI: 10.3390/biomimetics10010066.
RNA Coating Promotes Peri-Implant Osseointegration.
Zhang X, Chen Y, Zhou S, Liu Y, Zhu S, Jia X ACS Biomater Sci Eng. 2024; 10(11):7030-7042.
PMID: 38943625 PMC: 11558559. DOI: 10.1021/acsbiomaterials.4c00133.
Surface-modified titanium and titanium-based alloys for improved osteogenesis: A critical review.
Li J, Zheng Y, Yu Z, Kankala R, Lin Q, Shi J Heliyon. 2024; 10(1):e23779.
PMID: 38223705 PMC: 10784177. DOI: 10.1016/j.heliyon.2023.e23779.
Li Y, Ye Z, Yang H, Xu Q Acta Pharm Sin B. 2022; 12(6):2624-2639.
PMID: 35755280 PMC: 9214058. DOI: 10.1016/j.apsb.2022.04.013.